Last synced on 14 November 2025 at 11:06 pm

Advanta VXT Vascular Graft, Flixene Vascular Graft

Page Type
Cleared 510(K)
510(k) Number
K231972
510(k) Type
Traditional
Applicant
Atrium Medical Corporation
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
3/28/2024
Days to Decision
269 days
Submission Type
Summary

Advanta VXT Vascular Graft, Flixene Vascular Graft

Page Type
Cleared 510(K)
510(k) Number
K231972
510(k) Type
Traditional
Applicant
Atrium Medical Corporation
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
3/28/2024
Days to Decision
269 days
Submission Type
Summary